Chalice Brands Ltd.
CNSX:CHAL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Chalice Brands Ltd.
CNSX:CHAL
|
CA |
|
Access Intelligence PLC
LSE:ACC
|
UK |
|
S
|
SemCNS Co Ltd
KOSDAQ:252990
|
KR |
|
Television Francaise 1 SA
PAR:TFI
|
FR |
|
Future Data Group Ltd
HKEX:8229
|
KR |
|
Medexus Pharmaceuticals Inc
TSX:MDP
|
CA |
|
M
|
Mycron Steel Bhd
KLSE:MYCRON
|
MY |
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
ID |
|
A
|
Aritzia Inc
OTC:ATZAF
|
CA |
|
S
|
Shanghai Fudan Forward S&T Co Ltd
SSE:600624
|
CN |
Balance Sheet
Balance Sheet Decomposition
Chalice Brands Ltd.
Chalice Brands Ltd.
Balance Sheet
Chalice Brands Ltd.
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
4
|
6
|
12
|
4
|
1
|
|
| Cash |
0
|
4
|
6
|
12
|
4
|
1
|
|
| Total Receivables |
1
|
1
|
1
|
2
|
1
|
2
|
|
| Accounts Receivables |
1
|
0
|
0
|
1
|
0
|
0
|
|
| Other Receivables |
0
|
1
|
1
|
2
|
1
|
2
|
|
| Inventory |
1
|
1
|
4
|
3
|
3
|
3
|
|
| Other Current Assets |
1
|
3
|
1
|
2
|
0
|
1
|
|
| Total Current Assets |
3
|
9
|
12
|
20
|
8
|
6
|
|
| PP&E Net |
6
|
2
|
6
|
6
|
8
|
6
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
8
|
6
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
5
|
6
|
|
| Intangible Assets |
0
|
9
|
26
|
22
|
11
|
11
|
|
| Goodwill |
0
|
0
|
31
|
25
|
4
|
4
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
5
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
31
|
25
|
4
|
4
|
|
| Total Assets |
9
N/A
|
25
+171%
|
75
+202%
|
73
-2%
|
32
-57%
|
28
-11%
|
|
| Liabilities | |||||||
| Accounts Payable |
2
|
2
|
3
|
3
|
2
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
12
|
0
|
9
|
1
|
7
|
|
| Other Current Liabilities |
1
|
2
|
0
|
1
|
0
|
1
|
|
| Total Current Liabilities |
3
|
16
|
4
|
13
|
3
|
11
|
|
| Long-Term Debt |
3
|
12
|
40
|
14
|
18
|
11
|
|
| Other Liabilities |
5
|
0
|
14
|
0
|
0
|
0
|
|
| Total Liabilities |
11
N/A
|
28
+152%
|
58
+108%
|
27
-53%
|
21
-22%
|
23
+7%
|
|
| Equity | |||||||
| Common Stock |
15
|
34
|
109
|
139
|
148
|
150
|
|
| Retained Earnings |
18
|
37
|
91
|
92
|
137
|
147
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Equity |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
3
-61%
|
17
N/A
|
47
+169%
|
11
-77%
|
5
-48%
|
|
| Total Liabilities & Equity |
9
N/A
|
25
+171%
|
75
+202%
|
73
-2%
|
32
-57%
|
28
-11%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
3
|
5
|
21
|
26
|
37
|
42
|
|